CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Grant or award Director acquired 11,044 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,055 shares (to pay taxes)
- 4 Grant or award Director acquired 23,611 shares (grant or award)
- 4 Grant or award SVP, General Counsel acquired 102,689 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 155,200 shares (grant or award)
- 4 Grant or award Director acquired 23,611 shares (grant or award)
- 4 Grant or award Director acquired 23,611 shares (grant or award)
- 4 Grant or award Director acquired 23,611 shares (grant or award)
- 4 Grant or award Director acquired 23,611 shares (grant or award)
- 4 Grant or award Director acquired 23,611 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 424,000 shares (grant or award)
- 4 Open-market sale Director sold 25,890 shares at $4.51 ($116,764)
- 4 Open-market sale Director sold 25,821 shares at $4.51 ($116,453)
- 4 Shares withheld for taxes Chief Financial Officer gave up 16,408 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 38,621 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 10,951 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 92 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 703 shares (to pay taxes)
Page 6 of 20 · 394 filings